What is Travere Therapeutics, Inc.'s change in other assets?

Travere Therapeutics, Inc. (TVTX) reported change in other assets of $6.38M in Q1 2026.

How has Travere Therapeutics, Inc.'s change in other assets changed year-over-year?

Travere Therapeutics, Inc.'s change in other assets increased by 282.2% year-over-year, from $1.67M to $6.38M.

What is the long-term trend for Travere Therapeutics, Inc.'s change in other assets?

Over 2 years (2022 to 2025), Travere Therapeutics, Inc.'s change in other assets has grown at a 24.9% compound annual growth rate (CAGR), from $5.2M to $8.1M.

What does change in other assets mean?

Change in miscellaneous assets affecting operating cash flow.

Travere Therapeutics, Inc. TVTX Change in Other Assets

Change in Other Assets at other companies

LQD

Liquidia CorporationLQDA

$4.6M-0.5%

BridgeBio PharmaBBIO

$18.85M+3,770%

Arrowhead ResearchARWR

$13.18M+2,127%

PTC TherapeuticsPTCT

-$1.18M-107%

Scholar RockSRRK

$37K+142%

Protagonist TherapeuticsPTGX

$1.92M+102%

Other financials

Income statement

See full

Revenue$127.2M+55.6%

Gross profit$125.2M+62.5%

Operating income-$36.9M+13.5%

Net income-$37.1M+10.0%

EPS (diluted)-$0.40+14.9%

Balance sheet

See full

Cash & equivalents$78.4M+26.6%

Total debt$15.6M-82.6%

Total equity$98.7M+201%

Total assets$555.2M+1.2%

Cash flow

See full

Operating cash flow-$40.4M+4.3%

CapEx$140.0K—

Free cash flow-$42.5M+28.1%

Valuation

See full

Market cap$5.13B+72.3%

Enterprise value$5.07B+65.5%

P/S9.6×-1.3×

Profitability

See full

Gross margin98.6%+2.6pp

Operating margin-10.6%-5.0pp

Net margin-20.3%-9.5pp

FCF margin-133.9%-34.4pp

Returns & leverage

See full

Return on equity-706%-1,302pp

Debt / equity0.2×-2.6×

Current ratio3.1×+1.1×

Where this comes from

Reported directly by Travere Therapeutics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets.

The official record: Travere Therapeutics, Inc.’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →

Ask your AI about Travere Therapeutics, Inc.'s change in other assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Travere Therapeutics, Inc.'s change in other assets?: Travere Therapeutics, Inc. (TVTX) reported change in other assets of $6.38M in Q1 2026.
How has Travere Therapeutics, Inc.'s change in other assets changed year-over-year?: Travere Therapeutics, Inc.'s change in other assets increased by 282.2% year-over-year, from $1.67M to $6.38M.
What is the long-term trend for Travere Therapeutics, Inc.'s change in other assets?: Over 2 years (2022 to 2025), Travere Therapeutics, Inc.'s change in other assets has grown at a 24.9% compound annual growth rate (CAGR), from $5.2M to $8.1M.
What does change in other assets mean?: Change in miscellaneous assets affecting operating cash flow.